Recent Finacing
Recent Raise
SoniVie develops TIVUS, an ultrasound denervation platform with clinical programs for pulmonary/renal artery and lung denervation targeting pulmonary hypertension, resistant hypertension, and COPD; operations in Israel, US, Europe.
